Arkansas Jury Accepted Testimony by Expert David K.A. Mordecai for Bayer Cropscience

Print Friendly, PDF & Email

An Arkansas jury accepted testimony by expert David K.A. Mordecai for Bayer Cropscience. Compass Lexecon has been involved in the ongoing litigation related to the release of genetically modified rice into the domestic US rice supply by Bayer CropSciences in 2006. Hundreds of cases have been filed by US rice farmers and millers claiming they were damaged by the release because various countries curtailed rice imports in response to concerns that US rice might contain traces of genetically modified rice. Compass Lexecon was retained by Bartlit Beck Herman Palenchar & Scott LLPon behalf of Bayer CropScience to estimate damages to US rice farmers and millers. Compass Lexecon experts and affiliates submitted reports in a number of cases, only one of which has gone to trial at this point.

In that case, Compass Lexecon affiliate David K.A. Mordecai testified on behalf of Bayer, and the jury accepted his estimate of damages and rejected plaintiff’s experts’ estimate.

Compass Lexecon experts Professor Daniel Fischel and Dr. Gustavo Bamberger submitted reports in other cases, and Dr. Vincent Warther and Lynette Neumann headed up the support teams in the Chicago Compass Lexecon office. In connection with work in these cases, Compass Lexecon worked with Mark Ferguson, Eric Olson, Glen Summers, John Hughes, Les Houtz and others at Bartlit Beck Herman Palenchar & Scott LLP.

Doyle Sims, et al. vs. Bayer Cropscience, LP, et al., In the Circuit Court of Desha County, Arkansas, Civil Division, Case No. CV-2009-118-3, (damages from alleged contamination of U.S. rice crop), testimony at trial on behalf of Bayer defendants, July 2010.

Arkansas Jury Accepted Testimony by Expert David K.A. Mordecai for Bayer Cropscience

David K.A. Mordecai is President and Co-Founder of Risk Economics, a New York City based advisory firm. The Risk Economics® litigation advisory practice provides advisory services and testimonial expertise on complex issues related to financial instrument valuation models and frameworks, market and industry standards and practices for the financing, risk management, active trading, and hedging of OTC derivatives and structured products. Dr. Mordecai is Senior Advisor to, and a Member of the Advisory Committee of, Compass Lexecon.

As lead for the Risk Economics® litigation and arbitration advisory practice, David Mordecai serves as an expert on loss causation and economic damages related to market structure, financial institutions governance, and complex issues related to finance, economics and market standards and practices within securities, derivatives, reinsurance, and commodities markets, as well as market structure within a broad range of non-financial industry sectors. His expertise includes industrial and financial engineering, the valuation of fixed income securities and structured products, including over-the-counter derivatives (in particular fixed income and credit derivatives), complex insurance and reinsurance liabilities, as well as asset liability and risk management models and practices.